Former Mercy Iowa City CEO Ronald Reed dies at 64

Ronald Reed, former longtime CEO of Mercy Iowa City, died Feb. 6 at age 64 after a long battle with a chronic illness, according to The Gazette.

Advertisement

Mr. Reed served as CEO of Mercy Iowa City from 1995 until his retirement in 2016. During his tenure, he oversaw the expansion of the hospital’s services, including new primary care clinics, a wound and vein center and a hospice care unit.

In addition, Mr. Reed led Mercy Iowa City through a period of low inpatient admissions while Iowa City-based University of Iowa brought more services into the area. Despite the competition, Mr. Reed helped the hospital maintain a strong profit margin by developing niche markets.

“Our hope is we can continue to provide choice in the community,” Reed told The Gazette in 2015.

More articles on leadership and management:
Andy Slavitt launches new health policy nonprofit
The board’s role in strategic planning: Six “must ask” questions
The 1990s called — They want your hospital’s operating model back

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.